ArticleiScience2026
Metabolic and inflammatory burden modifies muscle cardiovascular association across aging cohorts within an intrinsic capacity framework.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the association between intrinsic capacity domains and incident cardiovascular disease across three nationally representative aging cohorts from the United States, the United Kingdom, and China. Harmonized data from HRS, ELSA, and CHARLS were analyzed using multivariable cause-specific Cox models with time-varying covariates where available. Among intrinsic capacity domains, muscle function showed the most consistent inverse association with cardiovascular risk across cohorts. Higher levels of systemic inflammatory and metabolic burden, including elevated C-reactive protein, diabetes, and non-HDL cholesterol, were associated with higher risk and with attenuation of the modeled muscle-cardiovascular association, with the strongest modification observed in CHARLS. A three-dimensional Metabolism-Inflammation-Muscle surface was used to visualize this interaction structure. These findings support muscle function as a cross-cohort marker of lower cardiovascular risk while highlighting its context-dependent magnitude under systemic stress. The proposed surface is descriptive and requires external validation before clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.